Stockscreener 앱 받기
84.63
2.81%
2.31
Ani Pharmaceuticals Inc 주식(ANIP)의 최신 뉴스
MSN Money - MSN
Hussman Strategic Advisors Inc. Takes Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Artemis Investment Management LLP Invests $1.71 Million in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
ANI Pharmaceuticals (ANIP) Announces Launch of Pimozide Tablets 1 mg and 2 mg - Insider Monkey
ANI Pharmaceuticals (ANIP) Expected to Announce Earnings on Friday - MarketBeat
Zacks.com featured highlights include Mirion Technologies, Intuit and ANI Pharmaceuticals - Yahoo Finance
9 Best Drug Stocks to Buy According to Analysts - Insider Monkey
NTLA Falls 4% Despite Strong Phase III HAE Data, Initiates Rolling BLA - TradingView
ANI Pharmaceuticals rolls out generic carbamazepine extended-release capsules - MSN
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
What ANI Pharmaceuticals (ANIP)'s Niche CNS Generic Launches Mean For Its Specialty-First Strategy - Sahm
Assessing ANI Pharmaceuticals (ANIP) Valuation After New U.S. Generic Drug Launches - Yahoo Finance
Organon Shares Rally 16% in Premarket as Sun Pharma Announces Buyout - TradingView
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET - marketscreener.com
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Passes Below 200-Day Moving AverageHere's Why - MarketBeat
Here's Why ANI Pharmaceuticals (ANIP) is a Strong Momentum Stock - Yahoo Finance
How Investors Are Reacting To ANI Pharmaceuticals (ANIP) New Generics Push And ILUVIEN Trial Data - Sahm
ANI Pharmaceuticals launches generic pimozide tablets By Investing.com - Investing.com India
ANI Pharmaceuticals' 2026 Catalysts Include Gout Push and New Generics - Yahoo Finance
Is ANIP Stock Undervalued at 10x Forward Earnings and $93 Target? - TradingView
ANIP's Cortrophin Gel Surge Powers 2026 Growth Outlook - Yahoo Finance
Here's Why ANI Pharmaceuticals (ANIP) is a Strong Growth Stock - Yahoo Finance
ANI Pharmaceuticals launches generic pimozide tablets - Investing.com
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity - The Manila Times
ANI Pharma (ANIP) Stock: Invest or Wait? (+3.65%) 2026-04-18Stop Loss Levels - Cổng thông tin điện tử tỉnh Lào Cai
ANI Pharmaceuticals (NASDAQ:ANIP) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat
Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL), ANI Pharmaceuticals (ANIP) and Amylyx Pharmaceuticals Inc (AMLX) - The Globe and Mail
ANI Pharmaceuticals News Highlights Undervalued Shares And New Specialty Generics - Sahm
Assessing ANI Pharmaceuticals (ANIP) Valuation After Recent Mixed Share Price Performance - Sahm
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
ANI Pharmaceuticals Launches Carbamazepine Extended-Release Capsules - Intellectia AI
ANI Pharmaceuticals launches generic carbamazepine capsules By Investing.com - Investing.com India
ANIP News | ANI PHARMACEUTICALS INC (NASDAQ:ANIP) - ChartMill
0.67%
2.13%
자본화:
|
볼륨(24시간):